The Federal Trade Commission found no evidence that antitrust regulations were breached in a deal between German drugmaker Bayer AG and a division of Teva Pharmaceuticals to end patent litigation over Bayer’s Yasmin birth control pill.
Fox Business reports that the FTC had been investigating a deal made by Bayer and Barr Laboratories, which was purchased by Teva, in 2008. It was supposed to settle a three-year fight over whether Barr ...
continue reading...